| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Jones Cecilia48 | Chief Financial Officer | Sale+OE | 672 | $32.57 | $21,887.04 | -4.3% | +39.7% | +8.2% | |
| Feb 27, 2024 | Schenkein David P59 | Director | Sale+OE | 69,329 | $34.67 | $2,403,591.99 | -22.0% | +11.5% | -1.1% | |
| Feb 26, 2024 | Schenkein David P59 | Director | Sale+OE | 68,142 | $33.09 | $2,254,950.64 | -21.7% | +18.1% | +7.1% | |
| Feb 20, 2024 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sell | 504 | $26.63 | $13,421.52 | -15.5% | +22.5% | +25.5% | |
| Feb 14, 2024 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sale+OE | 273 | $25.14 | $6,863.22 | -7.8% | +31.8% | +28.6% | |
| Feb 14, 2024 | Burns James William49 | Chief Legal Officer | Sale+OE | 545 | $25.14 | $13,701.30 | -1.7% | +31.8% | +28.6% | |
| Feb 14, 2024 | Gheuens Sarah49 | Chief Medical Officer | Sale+OE | 642 | $25.14 | $16,139.88 | -1.9% | +31.8% | +28.6% | |
| Jan 24, 2024 | Fouse Jacqualyn A | Director | Sale+OE | 10,722 | $21.64 | $232,024.08 | -7.7% | +47.9% | +64.5% | |
| Jan 24, 2024 | Burns James William49 | Chief Legal Officer | Sale+OE | 1,708 | $21.64 | $36,961.12 | -5.3% | +47.9% | +64.5% | |
| Jan 24, 2024 | Gheuens Sarah49 | Chief Medical Officer | Sale+OE | 1,708 | $21.64 | $36,961.12 | -5.1% | +47.9% | +64.5% |